Latest Insider Transactions at Natures Sunshine Products Inc (NATR)
This section provides a real-time view of insider transactions for Natures Sunshine Products Inc (NATR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NATURES SUNSHINE PRODUCTS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NATURES SUNSHINE PRODUCTS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 04
2022
|
Shirley Wu Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,181
+40.32%
|
-
|
|
May 04
2022
|
Robert D Straus Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,181
+17.36%
|
-
|
|
May 04
2022
|
John Christopher Teets Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,181
+13.18%
|
-
|
|
May 03
2022
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,147
-1.33%
|
$82,352
$16.48 P/Share
|
|
May 03
2022
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,077
+3.27%
|
-
|
|
Apr 06
2022
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,859
-1.02%
|
$61,744
$16.77 P/Share
|
|
Apr 06
2022
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,805
+2.53%
|
-
|
|
Apr 06
2022
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,226
-0.81%
|
$19,616
$16.77 P/Share
|
|
Apr 06
2022
|
Joseph W Baty EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,482
+2.87%
|
-
|
|
Apr 06
2022
|
Nathan G Brower EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
462
-1.12%
|
$7,392
$16.77 P/Share
|
|
Apr 06
2022
|
Nathan G Brower EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,913
+4.42%
|
-
|
|
Apr 06
2022
|
Daniel C Norman EVP & President, Asia |
SELL
Payment of exercise price or tax liability
|
Direct |
662
-1.05%
|
$10,592
$16.77 P/Share
|
|
Apr 06
2022
|
Daniel C Norman EVP & President, Asia |
BUY
Exercise of conversion of derivative security
|
Direct |
2,716
+4.13%
|
-
|
|
Apr 06
2022
|
Bryant J Yates EVP & President, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
662
-0.87%
|
$10,592
$16.77 P/Share
|
|
Apr 06
2022
|
Bryant J Yates EVP & President, Europe |
BUY
Exercise of conversion of derivative security
|
Direct |
2,716
+3.44%
|
-
|
|
Apr 06
2022
|
Edward Silcock EVP & President, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
662
-1.83%
|
$10,592
$16.77 P/Share
|
|
Apr 06
2022
|
Edward Silcock EVP & President, North America |
BUY
Exercise of conversion of derivative security
|
Direct |
2,716
+6.97%
|
-
|
|
Apr 01
2022
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,021
-1.34%
|
$85,357
$17.2 P/Share
|
|
Apr 01
2022
|
Edward Silcock EVP & President, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
855
-2.49%
|
$14,535
$17.2 P/Share
|
|
Mar 30
2022
|
Daniel C Norman EVP & President, Asia |
SELL
Payment of exercise price or tax liability
|
Direct |
844
-1.38%
|
$13,504
$16.79 P/Share
|
|
Mar 30
2022
|
Bryant J Yates EVP & President, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
844
-1.13%
|
$13,504
$16.79 P/Share
|
|
Mar 30
2022
|
Nathan G Brower EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
573
-1.43%
|
$9,168
$16.79 P/Share
|
|
Mar 30
2022
|
Edward Silcock EVP & President, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
829
-2.35%
|
-
|
|
Mar 30
2022
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,811
-1.87%
|
$44,976
$16.79 P/Share
|
|
Mar 29
2022
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,267
-2.93%
|
$191,539
$17.15 P/Share
|
|
Mar 26
2022
|
Nathan G Brower EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
637
-1.57%
|
$10,829
$17.23 P/Share
|
|
Mar 26
2022
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,181
-0.78%
|
$20,077
$17.23 P/Share
|
|
Mar 26
2022
|
Daniel C Norman EVP & President, Asia |
SELL
Payment of exercise price or tax liability
|
Direct |
614
-0.99%
|
$10,438
$17.23 P/Share
|
|
Mar 26
2022
|
Edward Silcock EVP & President, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
776
-2.16%
|
$13,192
$17.23 P/Share
|
|
Mar 26
2022
|
Bryant J Yates EVP & President, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
614
-0.82%
|
$10,438
$17.23 P/Share
|
|
Mar 18
2022
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,147
-1.32%
|
$87,499
$17.03 P/Share
|
|
Mar 18
2022
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,077
+3.25%
|
-
|
|
Mar 02
2022
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,389
-0.63%
|
$40,613
$17.42 P/Share
|
|
Mar 02
2022
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,804
+2.52%
|
-
|
|
Mar 02
2022
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,226
-0.8%
|
$20,842
$17.42 P/Share
|
|
Mar 02
2022
|
Joseph W Baty EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,482
+2.86%
|
-
|
|
Jan 25
2022
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,177
-0.85%
|
$54,009
$17.86 P/Share
|
|
Jan 25
2022
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,077
+3.39%
|
-
|
|
Jan 21
2022
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
25,000
+25.15%
|
$200,000
$8.72 P/Share
|
|
Jan 14
2022
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,790
-0.77%
|
$50,220
$18.61 P/Share
|
|
Jan 14
2022
|
Terrence Moorehead Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,804
+2.64%
|
-
|
|
Jan 14
2022
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,463
-0.98%
|
$26,334
$18.61 P/Share
|
|
Jan 14
2022
|
Joseph W Baty EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,481
+2.91%
|
-
|
|
Jan 07
2022
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
9,558
+16.21%
|
-
|
|
Jan 03
2022
|
Tess Roering Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,155
+50.0%
|
-
|
|
Jan 03
2022
|
Curtis Kopf Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,155
+50.0%
|
-
|
|
Jan 03
2022
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,526
-1.04%
|
$27,468
$18.5 P/Share
|
|
Oct 14
2021
|
Joseph W Baty EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,768
-1.19%
|
$24,752
$14.9 P/Share
|
|
Oct 14
2021
|
Joseph W Baty EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,481
+2.93%
|
-
|
|
Oct 14
2021
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,859
-1.08%
|
$54,026
$14.9 P/Share
|